Strategies to inhibit TGF-β signaling (SMADs and MRTFA) might limit the negative consequences of obesity by directly retaining the metabolic functions of adipocytes. This evidence concerns the gene TGFB1 and obesity due to melanocortin 4 receptor deficiency.